共 183 条
- [1] Thompson AJ(2001)Symptomatic management and rehabilitation in multiple sclerosis J Neurol Neurosurg Psychiatry 71 22-27
- [2] Henze T(2006)Symptomatic treatment of Multiple Sclerosis Eur Neurol 56 78-105
- [3] Rieckmann P(2006)AFFIRM Investigators. A randomised, placebo-controlled trial of natalizumab for relapsing multiple sclerosis N Engl J Med 354 899-910
- [4] Toyka KV(2000)High dose immunosupressive therapy with PBCP support in the treatment of poor risk multiple sclerosis Bone Marrow Transplant 25 525-531
- [5] Polman CH(1995)Low dose (7,5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis Ann Neurol 37 30-40
- [6] O'Connor PW(1991)Quantitative MRI changes in gadolinium-DPTA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis Neurology 41 1219-1222
- [7] Havrdova E(2002)Rehabilitation research-time for a change of focus The Lancet Neurology 1 209.-22
- [8] Hutchinson M(2002)Physical therapy in spasticity Eur J Neurol 9 17-130
- [9] Kappos L(2002)A paradigm shift in neurorehabilitation Lancet Neurol 1 126-31
- [10] Miller DH(2009)Plasticity in MS: from functional imaging to rehabilitation Int MS J 16 26-1235